A retrospective study investigating radiation dosimetry of 177Lu-PSMA imaging and therapy in metastatic castration-resistant prostate cancer
Latest Information Update: 19 May 2017
At a glance
- Drugs Lutetium (177Lu) vipivotide tetraxetan (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- 19 May 2017 New trial record